CURX
NASDAQ
$0.20
Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. The company is headquartered in Jericho, New York.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$6.11M
P/B Ratio
0.76
Beta (5Y)
1.18
Price Chart
Valuation
Market Cap$6.11M
P/B0.76
Profitability
EBITDA-$7.23M
EPS-$0.26
Growth & Risk
Beta (5Y)1.18
Sharpe Ratio-1.25